IL6 and lung carcinoma: Moreover, higher levels of IL-6 exists in NSCLC patients and shows an upward trend and IL-6 is associated with the pathogenesis and progression of lung cancer (Strassmann et al., 1992; Xu et al., 2002; Chang et al., 2013).